中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2010, Vol. 45 Issue (15) :1121-1126    DOI:
�� �� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
����ϵͳ����ѧ�Ķ�е㼰�����ҩ���о��Ľ�չ
�Ծ�1��2��������1*
1. ��ž��ڶ���ҽ��ѧҩѧԺ���Ϻ� 200433��2. ��ž����ڹ���ѧԺ��ѧ�����ң����� 400016

Download: PDF (1011KB)   HTML (0KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ������ǰ����ϵͳ����ѧ�Ķ�е㡢�����ҩ���о���һЩ����ͽ�չ������ ���׼������������ ��ǰҩ�﷢�ֵ�ԭ����Ҫ��ѭ��һҩ��һ��,һ�����������������뼲����ص�ijһ�ؼ��б������ϵĻ�ѧʵ�塣���ܹ�ȥ��ʮ���д����ѡ����ҩ�ﶼ��ͨ������������õģ��������ҩ��ȴ���ѴﵽԤ���ٴ�Ч������������صĶ������á���������ϵͳ����ѧ���о���ʾ�˷�����������뼲��֮��߶ȵĹ����ԣ�����ʾ����ϵͳ���淢�ְ��򼲲��������Ķ�е㡢�����ҩ��Ŀ����ԡ�����ͨ��������ף�������ѡ����ҩ����Ƶ�ȱ�ݣ��������˻���ϵͳ����ѧ�Ķ�е㡢�����ҩ���о���һЩ����ͽ�չ������ ��ҩ���о���ϵͳ����ѧ��ϣ��ڸ��ֵ�������ı������о�����е�֮�����������ϵ���п���ϵͳ��Ԥ��ͽ���ҩ������ã�����Ӱ��ҩ����Ч�ԺͰ�ȫ�Ե����أ��Ӷ������µ����Ƹ��Ӽ����IJ��ԣ����������µĶ�е㼰�����ҩ�
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
�ؼ����� ѡ����ҩ��   ��е�ҩ��   �����ҩ��   ��������   ϵͳ����ѧ     
Abstract��
Keywords��   
�ո�����: 2012-01-01;
���ñ���:   
.����ϵͳ����ѧ�Ķ�е㼰�����ҩ���о��Ľ�չ[J]  �й�ҩѧ��־, 2010,V45(15): 1121-1126
.[J]  Chinese Pharmaceutical Journal, 2010,V45(15): 1121-1126
��
[1] ADAMS C P�� BRANTNER V V. Estimating the cost of new drug development�� Is it really 802 million dollars? [J]. Health Aff (Millwood) �� 2006�� 25��2����420-428. [2] KAUFMANN S H E. Paul Ehrlich�� founder of chemotherapy [J]. Nat Rev Drug Discov �� 2008�� 7��5����373. [3] KOLA I�� LANDIS J. Can the pharmaceutical industry reduce attrition rates? [J]. Nat Rev Drug Discov �� 2004�� 3(8)��711-716. [4] WISHART D S�� KNOX C�� GUO A C�� et al. Drug-bank�� a comprehensive resource for in silico drug discovery and exploration [J]. Nucl Acid Res �� 2006�� 34(Database Issue)��668-672. [5] MAMDANI M�� ROCHON P A�� JUURLINK D N�� et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclooxygenase 2 inhibitors or conventional nonsteroidal antiinflammatory drugs [J]. Br Med J �� 2002�� 325��624. [6] STAFFA J A�� CHANG J�� GREEN L. Cerivastatin and reports of fatal rhabdomyolysis [J]. N Engl J Med �� 2002�� 346(7)��539-540. [7] MILLAN M J. Multi-target strategies for the improved treatment of depressive states��Conceptual foundations and neuronal substrates�� drug discovery and therapeutic application [J]. Pharmacol Ther�� 2006�� 110(2)��135-370. [8] LIU M�� LIBERZON A�� KONG S W�� et al. Network-based analysis of affected biological processes in type 2 diabetes models [J]. PLoS Genet�� 2007�� 3(6)��e96. [9] WHEELER-JONES C P D. Cell signaling in the cardiovascular system: an overview[J]. Heart, 2005, 91��10��: 1366-1374.[10] ENGELMAN J A�� SETTLEMAN J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy [J]. Curr Opin Genet Dev�� 2008�� 18(1)��73-79. [11] WONG D�� WANG M�� CHENG Y�� et al. Cardiovascular hazard and non-steroidal anti-inflammatory drugs [J]. Curr Opin Pharmacol�� 2005�� 5(2)��204-210. [12] LIPTON S A. Turning down�� but not off. Neuroprotection requires a paradigm shift in drug development. [J]. Nature�� 2004�� 428�� 473. [13] APIC G�� IGNJATOVIC T�� BOYER S�� et al. Illuminating drug discovery with biological pathways [J]. FEBS Lett�� 2005�� 579(8)��1872-1877. [14] CSERMELY P�� AGOSTON V�� PONGOR S. The efficiency of multi-target drugs�� the network approach might help drug design [J]. TRENDS Pharmacol Sci�� 2005�� 26(4)��178-182. [15] ARAUJO R P�� PETRICOIN E F�� LIOTTA L A. A mathematical model of combination therapy using the EGFR signaling network [J]. Biosystems�� 2005�� 80(1)��57-69. [16] CHOU T C. Theoretical basis�� experimental design�� and computerized simulation of synergism and antagonism in drug combination studies [J]. Pharmacol Rev�� 2006�� 58(3)��621-681. [17] LOEWE S�� MUISCHNEK H. Effect of combinations�� mathematical basis of the problem [J]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol�� 1926�� 114(5)��313-326. [18] KEITH C T�� BORISY A A�� STOCKWELL B R. Multicomponent therapeutics for networked systems [J]. Nat Rev Drug Discov�� 2005�� 4(1)��1-8. [19] BORISY A A�� ELLIOTT P J�� HURST N W, et al. Systematic discovery of multicomponent therapeutics [J]. Proc Natl Acad Sci USA�� 2003�� 100(13)��7977-7982. [20] BLISS C I. The toxicity of poisons applied jointly [J]. Ann Appl Biol�� 1939�� 26(13)��585-615. [21] WONG P K�� YU F�� SHAHANGIAN A�� et al. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm [J]. Proc Natl Acad Sci USA�� 2008�� 105(13)��5105-5110. [22] CALZOLARI D�� BRUSCHI S�� COQUIN L�� et al. Search algorithms as a framework for the optimization of drug combinations [J]. PLoS Comput Biol�� 2008�� 4(12)��e1000249. [23] ZINNER R G�� BARRETT B L�� POPOVA E, et al. Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells [J]. Mol Cancer Ther�� 2009�� 8(3)��521-532. [24] WANG Y�� YU L�� ZHANG L�� et al. A novel methodology for multicomponent drug design and its application in optimizing the combination of active components from Chinese medicinal formula shenmai [J]. Chem Biol Drug Des�� 2010�� 75(3)�� 318-324. [25] KITANO H. Biological robustness [J]. Nat Rev Genet�� 2004�� 5(11)��826-837. [26] ZHAO J�� YU H�� LUO J�� et al. Hierarchical modularity of nested bow-ties in metabolic networks [J]. BMC Bioinformatics�� 2006�� 7��386. [27] ZHAO J�� TAO L�� YU H�� et al. Bow-tie topological features of metabolic networks and the functional significance [J]. Chin Sci Bull�� 2007�� 52(8)��1036-1045. [28] JEONG H�� MASON S P�� BARABASI A L�� et al. Lethality and centrality in protein networks [J]. Nature�� 2001�� 411(6833)��41-42. [29] ZHAO J�� GENG C�� TAO L�� et al. Reconstruction and analysis of human liver-specific metabolic network based on CNHLPP data [J]. J Proteome Res�� 2010�� 9 (4)��1648-1658. [30] HWANG S�� SON S W�� KIM S C�� et al. A protein interaction network associated with asthma [J]. J Theor Biol�� 2008�� 252(4)��722-731. [31] RAHMAN S A�� SCHOMBURG D. Observing local and global properties of metabolic pathways�� "load points" and "choke points" in the metabolic networks [J]. Bioinformatics�� 2006�� 22��14��: 1767-1774. [32] HWANG W�� ZHANG A�� RAMANATHAN M. Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery[J]. Clin Pharmacol Ther, 2008, 84��5��:563-572.[33] DEZSO Z�� NIKOLSKY Y�� NIKOLSKAYA T�� et al. Identifying disease-specific genes based on their topological significance in protein networks [J]. BMC Systems Biol�� 2009�� 3��36. [34] HOPKINS A L. Network pharmacology�� the next paradigm in drug discovery [J]. Nat Chem Biol�� 2008�� 4(11)��682-690. [35] WU Z�� LUONAN C�� A Network-based Approach for Identifying Effective Drug Combination[C]. The Third International Symposium on Optimization and Systems Biology (OSB 09)�� 2009; Zhangjiajie�� China; 2009�� 207-213. [36] RUTHS D A�� NAKHLEH L�� IYENGAR M S�� et al. Hypothesis generation in signaling networks [J]. J Comput Biol�� 2006�� 13(9)��1546-1557. [37] DASIKA M S�� BURGARD A�� MARANAS C D. A computational framework for the topological analysis and targeted disruption of signal transduction networks [J]. Biophys J�� 2006�� 91(1)��382-398. [38] SRIDHAR P�� SONG B�� KAHVECIY T�� et al. Mining metabolic networks for optimal drug targets [J]. Pac Symp Biocomput�� 2008�� 13(1)��291-302. [39] KARLEBACH G�� SHAMIR R. Minimally perturbing a gene regulatory network to avoid a disease phenotype�� the glioma network as a test case [J]. BMC Systems Biology�� 2010�� 4��1����15. [40] YANG K�� BAI H�� OUYANG Q�� et al. Finding multiple target optimal intervention in disease-related molecular network [J]. Mol Syst Biol�� 2008�� 4��228. [41] LE NOVERE N�� BORNSTEIN B�� BROICHER A�� et al. BioModels Database�� a free�� centralized database of curated�� published�� quantitative kinetic models of biochemical and cellular systems [J]. Nucl Acid Res�� 2006�� 34(Database Issue)��D689-691. [42] SCHULZ M�� BAKKER B�� KLIPP E. TIde�� a software for the systematic scanning of drug targets in kinetic network models [J]. BMC Bioinformatics�� 2009�� 10��344. [43] OKA H�� YAMAMOTO S�� KUROKI T�� et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). [J]. Cancer�� 1995�� 76(5)��743-749. [44] HUANG S�� GUO A�� XIANG Y�� et al. Clinical study on the treatment of acute promyelocytic leukemia with composite indigo naturalis tablets [J]. Chin J Hematol(�л�ѪҺѧ��־)�� 1995�� 16(1)��26-28. [45] MAZZA M�� CAPUANO A�� BRIA P�� et al. Ginkgo biloba and donepezil�� a comparison in the treatment of Alzheimer��s dementia in a randomized placebo-controlled double-blind study [J]. Eur J Neurol�� 2006�� 13(9)��981-985. [46] SMALL E�� FROHLICH M�� BOK R�� et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer [J]. J Clin Oncol�� 2000 18(21)��3595-3603. [47] BONHAM M�� ARNOLD H�� MONTGOMERY B�� et al. Molecular effects of the herbal compound PC-SPES�� identification of activity pathways in prostate carcinoma [J]. Cancer Res�� 2002�� 62(14)��3920-3924. [48] ZHAO J�� JIANG P�� ZHANG W. Molecular networks for the study of TCM pharmacology [J]. Briefings in Bioinformatics�� 2009�� doi��10. 1093/bib/bbp063. [49] JIANG P�� LIU R�� DOU S�� et al. Analysis of the constituents in the rat plasma after oral administration of Shexiang Baoxin Pill by HPLC-ESI-MS/MS [J]. Biomed Chromatogr�� 2009��23(12)��1333-1343. [50] YUE Q X�� CAO Z W�� GUAN S H�� et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network [J]. Mol Cell Proteomics�� 2008�� 7(5)��949-961. [51] DUNKEL M�� GUNTHER S�� AHMED J�� et al. SuperPred�� drug classification and target prediction [J]. Nucleic Acids Res�� 2008�� 36 (Web Server issue)�� W55-W59. [52] CHEN Y Z�� ZHI D G. Ligand protein inverse docking and its potential use in the computer search of protein targets of a small molecule [J]. Proteins�� 2001�� 43(2)��217-226. [53] WANG L�� ZHOU G B�� LIU P�� et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia [J]. Proc Natl Acad Sci USA�� 2008�� 105(12)��4826-4831.
û���ҵ������������
Copyright 2010 by �й�ҩѧ��־